![]() |
Name |
Butyrolactone V
|
Molecular Formula | C24H24O8 | |
IUPAC Name* |
methyl (2R)-4-hydroxy-2-[[(3S)-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-6-yl]methyl]-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate
|
|
SMILES |
CC1([C@H](CC2=C(O1)C=CC(=C2)C[C@@]3(C(=C(C(=O)O3)O)C4=CC=C(C=C4)O)C(=O)OC)O)C
|
|
InChI |
InChI=1S/C24H24O8/c1-23(2)18(26)11-15-10-13(4-9-17(15)31-23)12-24(22(29)30-3)19(20(27)21(28)32-24)14-5-7-16(25)8-6-14/h4-10,18,25-27H,11-12H2,1-3H3/t18-,24+/m0/s1
|
|
InChIKey |
NSXYYYUKWBLFQH-MHECFPHRSA-N
|
|
Synonyms |
Butyrolactone V; 1151509-01-1; (2R)-2-[[(3S)-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl]methyl]-2,5-dihydro-4-hydroxy-3-(4-hydroxyphenyl)-5-oxo-2-Furancarboxylic acid, methyl ester; methyl (2R)-4-hydroxy-2-[[(3S)-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-6-yl]methyl]-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate; Butyrolactone derivative; CHEMBL2035563; HY-N8383; CS-0143793; J3.646.199C; (R)-4-Hydroxy-2-[[(S)-2,2-dimethyl-3-hydroxy-3,4-dihydro-2H-1-benzopyran-6-yl]methyl]-3-(4-hydroxyphenyl)-5-oxo-2,5-dihydrofuran-2-carboxylic acid methyl ester; methyl (2R)-4-hydroxy-2-[[(3S)-3-hydroxy-2,2-dimethyl-chroman-6-yl]methyl]-3-(4-hydroxyphenyl)-5-oxo-furan-2-carboxylate
|
|
CAS | NA | |
PubChem CID | 70685955 | |
ChEMBL ID | CHEMBL2035563 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 440.4 | ALogp: | 2.8 |
HBD: | 3 | HBA: | 8 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 123.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 32 | QED Weighted: | 0.62 |
Caco-2 Permeability: | -5.096 | MDCK Permeability: | 0.00002190 |
Pgp-inhibitor: | 0.339 | Pgp-substrate: | 0.045 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.193 |
30% Bioavailability (F30%): | 0.98 |
Blood-Brain-Barrier Penetration (BBB): | 0.084 | Plasma Protein Binding (PPB): | 96.44% |
Volume Distribution (VD): | 0.349 | Fu: | 3.19% |
CYP1A2-inhibitor: | 0.047 | CYP1A2-substrate: | 0.534 |
CYP2C19-inhibitor: | 0.845 | CYP2C19-substrate: | 0.389 |
CYP2C9-inhibitor: | 0.864 | CYP2C9-substrate: | 0.685 |
CYP2D6-inhibitor: | 0.119 | CYP2D6-substrate: | 0.416 |
CYP3A4-inhibitor: | 0.89 | CYP3A4-substrate: | 0.599 |
Clearance (CL): | 11.101 | Half-life (T1/2): | 0.264 |
hERG Blockers: | 0.11 | Human Hepatotoxicity (H-HT): | 0.595 |
Drug-inuced Liver Injury (DILI): | 0.653 | AMES Toxicity: | 0.078 |
Rat Oral Acute Toxicity: | 0.682 | Maximum Recommended Daily Dose: | 0.948 |
Skin Sensitization: | 0.084 | Carcinogencity: | 0.648 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
Respiratory Toxicity: | 0.098 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003498 | ![]() |
0.845 | D06TJJ | ![]() |
0.301 | ||
ENC002561 | ![]() |
0.794 | D0Q9ON | ![]() |
0.275 | ||
ENC002376 | ![]() |
0.716 | D07MGA | ![]() |
0.274 | ||
ENC003721 | ![]() |
0.650 | D0J7RK | ![]() |
0.271 | ||
ENC002571 | ![]() |
0.633 | D01XBA | ![]() |
0.264 | ||
ENC000875 | ![]() |
0.632 | D0JY8T | ![]() |
0.258 | ||
ENC002729 | ![]() |
0.632 | D04UTT | ![]() |
0.258 | ||
ENC002552 | ![]() |
0.620 | D0AZ8C | ![]() |
0.257 | ||
ENC002705 | ![]() |
0.609 | D06HBQ | ![]() |
0.257 | ||
ENC002711 | ![]() |
0.609 | D00LFB | ![]() |
0.256 |